Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Peking-Tsinghua Center for Life Sciences, Beijing, P.R. China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, P.R. China; Department of Nephrology, The Second Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, P.R. China.
Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Peking-Tsinghua Center for Life Sciences, Beijing, P.R. China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, P.R. China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, P.R. China.
Semin Arthritis Rheum. 2018 Feb;47(4):524-529. doi: 10.1016/j.semarthrit.2017.07.004. Epub 2017 Aug 31.
Cardiovascular diseases (CVD) are the major causes of death in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) during long-term follow-up. This study investigated risk factors for cardiovascular events (CVE) and CVD-related mortality in Chinese AAV patients.
Five hundred and four AAV patients in our center were retrospectively included. The predictive value of variables associated with CVE- and CVD-related mortality were analyzed.
During follow-up of a median duration of 38 (range 1-228) months, 117 out of 504 patients had CVE. Independent predictors of CVE were age [increase by 10 years, hazard ratio (HR) 1.436, 95% confidence interval (CI) 1.187-1.736, p = 0.000], systolic blood pressure (increase by 10mmHg, HR = 1.171, 95% CI: 1.038-1.321, p = 0.010), estimated glomerular filtration rate (eGFR) (increase by 1mL/min/1.73m, HR = 0.992, 95% CI: 0.984-0.999, p = 0.020), high-density lipoprotein level (HR = 0.530, 95% CI: 0.303-0.926, p = 0.026) and the Birmingham Vasculitis Activity Score (BVAS) (HR = 1.039, 95% CI: 1.011-1.067, p = 0.006). Forty-one patients died from CVD. Independent predictors of CVD-related mortality were age (increase by 10 years; HR = 1.732, 95% CI: 1.237-2.426, p = 0.001), eGFR (increase by 1mL/min/1.73m, HR = 0.984, 95% CI: 0.970-0.997, p = 0.016), pre-existing CV disease (HR = 2.872, 95% CI: 1.503-5.487, p = 0.001) and BVAS (HR = 1.064, 95% CI: 1.018-1.113, p = 0.006). We further analyzed CVE- and CVD-related mortality after 2 years since diagnosis, and found BVAS were still an independent predictor of CVE- and CVD-related mortality.
Besides the traditional risk factors, BVAS at presentation was an independent predictor of CVE- and CVD-related mortality in patients with AAV.
在长期随访中,心血管疾病(CVD)是抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)患者死亡的主要原因。本研究旨在探讨中国 AAV 患者心血管事件(CVE)和 CVD 相关死亡率的危险因素。
回顾性纳入我院 504 例 AAV 患者。分析与 CVE 和 CVD 相关死亡率相关的变量的预测价值。
在中位随访时间为 38(范围 1-228)个月期间,504 例患者中有 117 例发生 CVE。CVE 的独立预测因素为年龄[每增加 10 岁,风险比(HR)为 1.436,95%置信区间(CI)为 1.187-1.736,p=0.000]、收缩压[每增加 10mmHg,HR=1.171,95%CI:1.038-1.321,p=0.010]、估算肾小球滤过率(eGFR)[每增加 1mL/min/1.73m,HR=0.992,95%CI:0.984-0.999,p=0.020]、高密度脂蛋白水平[HR=0.530,95%CI:0.303-0.926,p=0.026]和伯明翰血管炎活动评分(BVAS)[HR=1.039,95%CI:1.011-1.067,p=0.006]。41 例患者死于 CVD。CVD 相关死亡率的独立预测因素为年龄[每增加 10 岁,HR=1.732,95%CI:1.237-2.426,p=0.001]、eGFR[每增加 1mL/min/1.73m,HR=0.984,95%CI:0.970-0.997,p=0.016]、预先存在的 CV 疾病[HR=2.872,95%CI:1.503-5.487,p=0.001]和 BVAS[HR=1.064,95%CI:1.018-1.113,p=0.006]。我们进一步分析了诊断后 2 年的 CVE 和 CVD 相关死亡率,发现 BVAS 仍然是 CVE 和 CVD 相关死亡率的独立预测因素。
除传统危险因素外,BVAS 是 AAV 患者 CVE 和 CVD 相关死亡率的独立预测因素。